CDC- BRFSS – ACBS 2020 Adult Prevalence Table 8
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 315 | 53.8 | 4.6 | (44.8 – 62.8) |
| Connecticut | 297 | 44.5 | 4.9 | (34.9 – 54.1) |
| Florida | 281 | 45.9 | 5.8 | (34.5 – 57.3) |
| Georgia | 274 | 51.2 | 5.3 | (40.8 – 61.6) |
| Hawaii | 232 | 43.4 | 4.5 | (34.6 – 52.2) |
| Indiana | 290 | 53.2 | 4.1 | (45.2 – 61.2) |
| Iowa | 279 | 56.2 | 3.7 | (48.9 – 63.5) |
| Kansas | 223 | 54.6 | 5.4 | (44.0 – 65.2) |
| Maine | 391 | 56.3 | 4.7 | (47.1 – 65.5) |
| Maryland | 148 | 54.6 | 5.9 | (43.0 – 66.2) |
| Massachusetts | 234 | 60.1 | 4.2 | (51.9 – 68.3) |
| Michigan | 328 | 54.9 | 3.9 | (47.3 – 62.5) |
| Minnesota | 476 | 55.4 | 2.9 | (49.7 – 61.1) |
| Missouri | 254 | 70.4 | 4.0 | (62.6 – 78.2) |
| Montana | 235 | 53.5 | 4.6 | (44.5 – 62.5) |
| Nebraska | 420 | 52.7 | 3.7 | (45.4 – 60.0) |
| New Hampshire | 375 | 59.3 | 3.6 | (52.2 – 66.4) |
| New Jersey | 446 | 48.0 | 3.1 | (41.9 – 54.1) |
| New Mexico | 244 | 50.5 | 5.4 | (39.9 – 61.1) |
| New York | 179 | 53.1 | 5.4 | (42.5 – 63.7) |
| Ohio | 408 | 50.7 | 3.7 | (43.4 – 58.0) |
| Oregon | 232 | 57.6 | 4.0 | (49.8 – 65.4) |
| Pennsylvania | 178 | 58.6 | 5.2 | (48.4 – 68.8) |
| Rhode Island | 235 | 56.6 | 5.1 | (46.6 – 66.6) |
| Texas | 390 | 55.6 | 5.1 | (45.6 – 65.6) |
| Utah | 364 | 55.4 | 3.4 | (48.7 – 62.1) |
| Vermont | 377 | 52.3 | 3.8 | (44.9 – 59.7) |
| Wisconsin | 227 | 49.2 | 4.6 | (40.2 – 58.2) |
| Puerto Rico | 221 | 40.3 | 5.1 | (30.3 – 50.3) |
| 29 States / Area | 8,553 | 53.6 | 1.1 | (51.4 – 55.8) |
| Median | 53.8 | |||
| Range | 40.3-70.4 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf